4.7 Article

Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer

Journal

SCIENTIFIC REPORTS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep32735

Keywords

-

Funding

  1. Indian Statistical Institute, India

Ask authors/readers for more resources

Oral cancer generally progresses from precancerous lesions such as leukoplakia (LK), lichen planus (LP) and oral submucous fibrosis (OSMF). Since few of these precancers progress to cancers; it is worth to identify biological molecules that may play important roles in progression. Here, expression deregulation of 7 miRNAs (mir204, mir31, mir31*, mir133a, mir7, mir206 and mir1293) and their possible target genes in 23 cancers, 18 LK, 12 LP, 23 OSMF tissues compared to 20 healthy tissues was determined by qPCR method. Expression of mir7, mir31, mir31* and mir1293 was upregulated and that of mir133a, mir204 and mir206 was downregulated in cancer. Expression of most of these miRNAs was also upregulated in LK and LP tissues but not in OSMF. Expression deregulation of some of the target genes was also determined in cancer, LK and LP tissues. Significant upregulation of mir31 and downregulation of its target gene, CXCL12, in cancer, LK and LP tissues suggest their importance in progression of precancer to cancer. Expression upregulation of mir31 was also validated using GEO data sets. Although sample size is low, novelty of this work lies in studying expression deregulation of miRNAs and target genes in oral cancer and three types of precancerous lesions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Otorhinolaryngology

Anomalous innominate artery complicating tracheal surgical procedures

J. J. E. Sargunaraj, R. R. Paul, S. S. Mathews, R. R. A. Albert

Summary: For airway surgeons, radiological assessment of vascular structures in relation to the trachea prior to surgery is as important as the endoluminal airway assessment for the best outcome.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Article Computer Science, Information Systems

Multifractal Alterations in Oral Sub-Epithelial Connective Tissue During Progression of Pre-Cancer and Cancer

Debaleena Nawn, Sawon Pratiher, Subhankar Chattoraj, Debjani Chakraborty, Mousumi Pal, Ranjan Rashmi Paul, Srimonti Dutta, Jyotirmoy Chatterjee

Summary: The research focused on the sub-epithelium region of the oral mucosa, utilizing tissue characteristics for analysis. Tissue-index transmission patches were cropped and characterized for multi-scale spatial-deformation dynamics and local contour connectivity. The 2D multifractal detrended fluctuation analysis (2D-MFDFA) was used to explore discriminative multifractal signatures for healthy, oral potentially malignant disorders, and oral cancer tissue samples.

IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS (2021)

Letter Oncology

Quantitative in situ imaging and grading of oral precancer with attenuation corrected-optical coherence tomography

Biswajoy Ghosh, Avishek Bhandari, Mousumi Mandal, Ranjan Rashmi Paul, Mousumi Pal, Pabitra Mitra, Jyotirmoy Chatterjee

ORAL ONCOLOGY (2021)

Article Cell Biology

Comparative evaluation of proliferative potential and replicative senescence associated changes in mesenchymal stem cells derived from dental pulp and umbilical cord

Monalisa Das, Ankita Das, Ananya Barui, Ranjan Rashmi Paul

Summary: MSCs are potential sources for tissue regeneration and cell-based therapy, and can be isolated from various body tissues and biological waste sources. The source of MSCs influences their proliferation capacity and replicative senescence, urging the need for comparative studies to select appropriate stem cell sources for regenerative medicine applications in the future.

CELL AND TISSUE BANKING (2022)

Article Engineering, Electrical & Electronic

Multifractal Texture Analysis of Salivary Fern Pattern for Oral Pre-Cancers and Cancer Assessment

Neha Sharma, Debaleena Nawn, Sawon Pratiher, Sayani Shome, Ritam Chatterjee, Karabi Biswas, Mousumi Pal, Ranjan Rashmi Paul, Srimonti Dutta, Jyotirmoy Chatterjee

Summary: This study proposed a multifractal based methodology to quantitatively study the alteration of salivary fern pattern in different oral potentially malignant disorders and oral cancer. By elucidating the complexity and heterogeneity of these micro-structured patterns, the study demonstrated the potential discriminatory nature of the features extracted from multi-scale self-similarity of irregular patterns in different study groups for fast and cost effective screening of various oral lesions.

IEEE SENSORS JOURNAL (2021)

Meeting Abstract Oncology

Concordance of DNA damage repair (DDR) gene mutations in paired primary and metastatic prostate cancer (PC) samples.

Michael Thomas Schweizer, Smruthy Sivakumar, Hanna Tukachinsky, Ilsa Coleman, Navonil De Sarkar, Evan Y. Yu, Eric Quentin Konnick, Peter Nelson, Colin C. Pritchard, Robert B. Montgomery

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Endocrinology & Metabolism

Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations

Alexandra O. Sokolova, Catherine H. Marshall, Rebeca Lozano, Roman Gulati, Elisa M. Ledet, Navonil De Sarkar, Petros Grivas, Celestia S. Higano, Bruce Montgomery, Peter S. Nelson, David Olmos, Vadim Sokolov, Michael T. Schweizer, Todd A. Yezefski, Evan Y. Yu, Channing J. Paller, Oliver Sartor, Elena Castro, Emmanuel S. Antonarakis, Heather H. Cheng

Summary: The study found that prostate cancer patients with ATM and BRCA2 mutations have similar response to conventional therapies but significant differences in response to PARPi, indicating the need for different treatment strategies for these two genetic mutation groups.

PROSTATE (2021)

Article Oncology

Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA

Michael T. Schweizer, Smruthy Sivakumar, Hanna Tukachinsky, Ilsa Coleman, Navonil De Sarkar, Evan Y. Yu, Eric Q. Konnick, Peter S. Nelson, Colin C. Pritchard, Bruce Montgomery

Summary: DDR gene mutations are key actionable alterations for precision medicine strategies in advanced prostate cancer. Primary prostate tissue accurately reflects the mutational status of DDR genes in metastatic tissue, with potential mechanisms of resistance detected in ctDNA profiling.

JAMA ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Comprehensive Evaluation of PAXgene Fixation on Oral Cancer Tissues Using Routine Histology, Immunohistochemistry, and FTIR Microspectroscopy

Pooja Lahiri, Suranjana Mukherjee, Biswajoy Ghosh, Debnath Das, Basudev Lahiri, Shailendra Kumar Varshney, Mousumi Pal, Ranjan Rashmi Paul, Jyotirmoy Chatterjee

Summary: This study evaluated the application of the PAXgene tissue fixation system on oral tissues and found that PAXgene-fixed tissues showed significantly less tissue fall-off from slides, comparable morphology with formalin-fixed tissues, and slightly superior immunostaining for cancer-associated proteins without antigen retrieval. FTIR measurements revealed superior preservation of biomolecules in PAXgene-fixed tissues.

BIOMOLECULES (2021)

Article Medicine, Research & Experimental

Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer

Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, Ilsa Coleman, Gavin Ha, Lisa S. Ang, Emily A. Kohlbrenner, Sander B. Frank, Talina A. Nunez, Stephen J. Salipante, Eva Corey, Colm Morrissey, Eliezer Van Allen, Michael T. Schweizer, Michael C. Haffner, Radhika Patel, Brian Hanratty, Jared M. Lucas, Ruth F. Dumpit, Colin C. Pritchard, Robert B. Montgomery, Peter S. Nelson

Summary: The study identified genomic characteristics of HRR deficiency in a subset of metastatic prostate cancers, even in the absence of biallelic loss of core genes like BRCA2. These aberrations were strongly correlated with responses to PARPi and platinum chemotherapy, highlighting the importance of evaluating functional HRRd biomarkers for treatment allocation.

JCI INSIGHT (2021)

Article Oncology

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer

Ilsa M. Coleman, Navonil DeSarkar, Colm Morrissey, Li Xin, Martine P. Roudier, Erolcan Sayar, Dapei Li, Eva Corey, Michael C. Haffner, Peter S. Nelson

Summary: This study classified metastatic castration-resistant prostate cancers (mCRPC) into LumA, LumB, and Basal subtypes using the PAM50 breast cancer classification algorithm and investigated their association with treatment outcomes. The study found that the LumA subtype was enriched in TGFss and... pathways.

CLINICAL CANCER RESEARCH (2022)

Letter Clinical Neurology

Evaluation of SORL1 in Lewy Body Dementia Identifies No Significant Associations

Anindita Ray, Paolo Reho, Zalak Shah, Sonja W. Scholz

MOVEMENT DISORDERS (2022)

Article Medicine, Research & Experimental

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Michael D. Nyquist, Lisa S. Ang, Alexandra Corella, Ilsa M. Coleman, Michael P. Meers, Anthony J. Christiani, Cordell Pierce, Derek H. Janssens, Hannah E. Meade, Arnab Bose, Lauren Brady, Timothy Howard, Navonil De Sarkar, Sander B. Frank, Ruth F. Dumpit, James T. Dalton, Eva Corey, Stephen R. Plymate, Michael C. Haffner, Elahe A. Mostaghel, Peter S. Nelson

Summary: Prostate cancer is driven by androgen receptor activity, which can be targeted by selective androgen receptor modulators (SARMs) to inhibit tumor growth. SARMs have shown to activate AR program, repress MYC oncoprotein expression, and inhibit the growth of both castration-sensitive and castration-resistant prostate cancer. Further clinical investigation of SARMs for treating advanced prostate cancer is supported by these promising results.

JOURNAL OF CLINICAL INVESTIGATION (2021)

No Data Available